| scholarly article | Q13442814 |
| P50 | author | Akhil Chandra Banerjea | Q44593096 |
| P2093 | author name string | Sneh Lata | |
| Ritu Mishra | |||
| P2860 | cites work | HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase. | Q47592848 |
| Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation. | Q49900491 | ||
| p14ARF is capable of promoting HIV-1 tat degradation. | Q53483321 | ||
| Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. | Q53637010 | ||
| Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. | Q54649040 | ||
| Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function | Q58611466 | ||
| The endogenous Mus81-Eme1 complex resolves Holliday junctions by a nick and counternick mechanism | Q79120277 | ||
| Intrinsic disorder and function of the HIV-1 Tat protein | Q84182175 | ||
| ISG15 in antiviral immunity and beyond | Q88701533 | ||
| HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation | Q21089617 | ||
| Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps | Q21131559 | ||
| Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles | Q21559507 | ||
| Manipulation of dendritic cell function by viruses | Q21710678 | ||
| HIV-1 induced bystander apoptosis | Q22241221 | ||
| Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding | Q24291784 | ||
| The Protein Network of HIV Budding | Q24294993 | ||
| Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins | Q24296475 | ||
| Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding | Q24299705 | ||
| T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction | Q24300389 | ||
| Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 | ||
| Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain | Q24306855 | ||
| Modulation of HIV-1 Rev protein abundance and activity by polyubiquitination with unconventional Lys-33 branching | Q24309503 | ||
| Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing | Q24318920 | ||
| SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef | Q24338889 | ||
| Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus | Q24523226 | ||
| Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. | Q24523667 | ||
| Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases | Q24530147 | ||
| Analysis of human immunodeficiency virus type 1 Gag ubiquitination | Q24531968 | ||
| The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production | Q24557498 | ||
| Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 | Q24559906 | ||
| Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release | Q24563651 | ||
| The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
| Memory and the NMDA receptors | Q24603015 | ||
| Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
| ESCRT-III protein requirements for HIV-1 budding | Q24627115 | ||
| Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag) | Q24633537 | ||
| Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation | Q24643067 | ||
| Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism | Q24644811 | ||
| Human immunodeficiency virus vpr product is a virion-associated regulatory protein | Q24649600 | ||
| DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest | Q24671784 | ||
| Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle | Q24680705 | ||
| HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1 | Q24681112 | ||
| Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate | Q24683820 | ||
| Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity | Q24685633 | ||
| The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle | Q24685965 | ||
| Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV | Q27649242 | ||
| Structural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTR | Q27657031 | ||
| The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction | Q27727807 | ||
| Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination | Q27932737 | ||
| A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter | Q28190014 | ||
| CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms | Q28191684 | ||
| AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding | Q28204548 | ||
| HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress | Q28207991 | ||
| Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex | Q28210666 | ||
| 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1 | Q28238115 | ||
| Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
| Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex | Q28270521 | ||
| A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif | Q28276184 | ||
| The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA | Q28279502 | ||
| A genomic and functional inventory of deubiquitinating enzymes | Q28284911 | ||
| Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA | Q28286261 | ||
| Nucleotide sequence of the AIDS virus, LAV | Q28286313 | ||
| Polyubiquitin chains: polymeric protein signals | Q28294396 | ||
| A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 | Q28305429 | ||
| HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation | Q28306470 | ||
| Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces | Q28477489 | ||
| Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
| PDZ domain proteins of synapses | Q29616399 | ||
| Histone ubiquitination: triggering gene activity | Q29617523 | ||
| Control of RNA initiation and elongation at the HIV-1 promoter | Q29620157 | ||
| Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. | Q30379978 | ||
| HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane | Q30815492 | ||
| HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase | Q33290831 | ||
| Proteasomal degradation of TRIM5alpha during retrovirus restriction | Q33337129 | ||
| Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking | Q33455505 | ||
| Host cell factors in HIV replication: meta-analysis of genome-wide studies | Q33455551 | ||
| Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery | Q33567848 | ||
| HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation | Q33613221 | ||
| Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. | Q33635863 | ||
| Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. | Q33700568 | ||
| Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2. | Q33743176 | ||
| CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway | Q33782459 | ||
| The human immunodeficiency virus rev protein is a nuclear phosphoprotein | Q34534125 | ||
| Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
| The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor | Q34647751 | ||
| Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. | Q34701164 | ||
| Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation | Q34784600 | ||
| Tight regulation of unstructured proteins: from transcript synthesis to protein degradation | Q34890013 | ||
| HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP. | Q35015138 | ||
| ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction | Q35579416 | ||
| Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. | Q35665886 | ||
| Interferon targeted genes in host defense | Q35675514 | ||
| Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors | Q35758867 | ||
| The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation | Q35776289 | ||
| HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest. | Q35837172 | ||
| Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. | Q35890940 | ||
| HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins | Q35895988 | ||
| Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain | Q35922462 | ||
| Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs | Q36168643 | ||
| PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density | Q36394413 | ||
| Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages | Q36400526 | ||
| HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination | Q36436143 | ||
| Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance | Q36492916 | ||
| HIV-1 pathogenesis: the virus | Q36526530 | ||
| The ubiquitin-proteasome pathway in viral infections | Q36538328 | ||
| Host restriction factors in retroviral infection: promises in virus-host interaction | Q36548179 | ||
| Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. | Q36633274 | ||
| Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells | Q36651389 | ||
| Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes | Q36685112 | ||
| Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 | Q36687143 | ||
| APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated | Q36726563 | ||
| Deubiquitination in virus infection | Q36732782 | ||
| Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus | Q36793300 | ||
| Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein | Q36830393 | ||
| HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation | Q36877203 | ||
| Inhibition of β-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells | Q39552474 | ||
| Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation. | Q39557790 | ||
| BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. | Q39580598 | ||
| β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release | Q39594626 | ||
| Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G. | Q39608648 | ||
| Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif. | Q39741166 | ||
| Functions of Linear Ubiquitin Chains in the NF-κB Pathway : Linear Polyubiquitin in NF-κB Signaling. | Q39794933 | ||
| Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest | Q39880367 | ||
| ISGylation - a key to lock the cell gates for preventing the spread of threats | Q40079195 | ||
| Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association | Q40112050 | ||
| HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system | Q40121880 | ||
| Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein | Q40143694 | ||
| PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription | Q40272529 | ||
| HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses | Q40400941 | ||
| Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus | Q40435980 | ||
| Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function | Q40444285 | ||
| Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation | Q40485830 | ||
| Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation | Q40514892 | ||
| HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation | Q40551410 | ||
| The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin | Q40580159 | ||
| HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites | Q40677862 | ||
| The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. | Q40816820 | ||
| Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome | Q40863490 | ||
| HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo | Q41071784 | ||
| HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1). | Q41172672 | ||
| The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway | Q41748165 | ||
| Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication | Q44004509 | ||
| Viruses and the 26S proteasome: hacking into destruction | Q44310046 | ||
| The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G | Q44653976 | ||
| NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP. | Q44692715 | ||
| Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation | Q45362793 | ||
| Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins. | Q47138132 | ||
| The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells | Q33782776 | ||
| Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates | Q33806395 | ||
| The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation | Q33815533 | ||
| The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process | Q33826592 | ||
| Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase | Q33908716 | ||
| Ubiquitin in chains | Q33925675 | ||
| Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences | Q33930053 | ||
| Degradation of oxidized proteins by the 20S proteasome. | Q33941917 | ||
| Taking a bite: proteasomal protein processing | Q33958918 | ||
| Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. | Q33962101 | ||
| p53 proteasomal degradation: poly-ubiquitination is not the whole story | Q33989179 | ||
| ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. | Q33991996 | ||
| 20S proteasomes and protein degradation "by default". | Q33998904 | ||
| HIV-1 Vpr redirects host ubiquitination pathway | Q34059218 | ||
| Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm | Q34060474 | ||
| Ubiquitin in retrovirus assembly: actor or bystander? | Q34087687 | ||
| The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
| HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation | Q34140089 | ||
| Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. | Q34146128 | ||
| Identification and characterization of the human mus81-eme1 endonuclease | Q34193657 | ||
| Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection | Q34242229 | ||
| p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease | Q34288376 | ||
| Modulation of the stability and activities of HIV-1 Tat by its ubiquitination and carboxyl-terminal region | Q34363381 | ||
| Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection | Q34465108 | ||
| The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors | Q36881276 | ||
| HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages | Q36904912 | ||
| Curcumin inhibits HIV-1 by promoting Tat protein degradation | Q36990763 | ||
| Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation | Q37010047 | ||
| MDM2 is a novel E3 ligase for HIV-1 Vif. | Q37069041 | ||
| Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion | Q37115275 | ||
| Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding | Q37116827 | ||
| The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection | Q37126033 | ||
| A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. | Q37235659 | ||
| HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation | Q37371813 | ||
| HIV accessory proteins versus host restriction factors | Q37375080 | ||
| The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor | Q37415400 | ||
| CD4 and BST-2/tetherin proteins retro-translocate from endoplasmic reticulum to cytosol as partially folded and multimeric molecules | Q37428581 | ||
| NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway. | Q37504979 | ||
| HIV-1 Nef down-modulates C-C and C-X-C chemokine receptors via ubiquitin and ubiquitin-independent mechanism | Q37529530 | ||
| Antiviral activity of innate immune protein ISG15. | Q37579660 | ||
| Cellular & molecular basis of HIV-associated neuropathogenesis. | Q37582716 | ||
| Immune regulator ABIN1 suppresses HIV-1 transcription by negatively regulating the ubiquitination of Tat. | Q37638282 | ||
| Host factors mediating HIV-1 replication | Q37922877 | ||
| The antiviral activities of ISG15. | Q38149665 | ||
| HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages. | Q38265455 | ||
| Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. | Q38332969 | ||
| Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes. | Q38626145 | ||
| HIV-1 Tat potently stabilises Mdm2 and enhances viral replication | Q38705008 | ||
| USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein | Q38712887 | ||
| HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells | Q38718438 | ||
| Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation | Q38739726 | ||
| SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr). | Q38761101 | ||
| The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks | Q38774142 | ||
| G2/M cell cycle arrest correlates with primate lentiviral Vpr interaction with the SLX4 complex. | Q38947343 | ||
| The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. | Q39155657 | ||
| LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway. | Q39158488 | ||
| A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. | Q39315034 | ||
| Structure and Function of Viral Deubiquitinating Enzymes. | Q39381317 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2738 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Proteasomal Degradation Machinery: Favorite Target of HIV-1 Proteins | |
| P478 | volume | 9 |
Search more.